Chinese Academy of Medical Sciences: Lung Neoplasms trials

The registry lists 21 Lung Neoplasms studies with Chinese Academy of Medical Sciences as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 9Phase 3 5No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour ResectionEnrolling by invitationNCT04762459Phase 3
• A Study of Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated With ChemoradiotherapyRecruitingNCT04749394Phase 2
• Prophylactic Cranial Irradiation in Extensive-stage Small Cell Lung CancerStatus unknownNCT04947774
• Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLCStatus unknownNCT04683198Phase 2
• PCI for Patients With ES-SCLC After RCT:a Prospective Randomized StudyStatus unknownNCT04535739Phase 3
• Simultaneous Integrated Boost vs. Routine IMRT in Limited-stage Small-cell Lung CancerStatus unknownNCT04500145Phase 3
• Real-world Treatment Patterns and Clinical Outcomes in EGFR-mutant Unresectable Locally Advanced NSCLCStatus unknownNCT04304638
• Monitoring Efficacy of Radiotherapy in Lung Cancer and Esophageal CancerStatus unknownNCT04014465
• PD-1 Inhibitors Consolidation in Extensive-stage Small Cell Lung CancerStatus unknownNCT03971214Phase 1
• TKI Followed by Thoracic Radiotherapy for Stage IV EGFR Mutant NSCLCStatus unknownNCT03916913Not applicable
• A Hospital Based Survey on Lung Cancer Related-pain in Northern ChinaStatus unknownNCT03189277
• Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)Status unknownNCT02995187Phase 2
• Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR MutationStatus unknownNCT02961270Phase 2
• The Effect of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With ChemotherapyStatus unknownNCT02771756Not applicable
• Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung CancerStatus unknownNCT02675088Not applicable
• Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung CancerCompletedNCT02323737Phase 2
• Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung CancerStatus unknownNCT01969955Phase 2
• Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional RegimenStatus unknownNCT01850147Phase 2
• Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer (NSCLC)Status unknownNCT01503385Phase 2
• Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung CancerCompletedNCT01494558Phase 2/3
• Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung CancerCompletedNCT00880971Phase 3